|
KIFC1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62625468647093E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.13309999999423E-05 |
| Normal-vs-Stage2 |
2.714100E-02 |
| Normal-vs-Stage3 |
3.57100000000221E-05 |
| Normal-vs-Stage4 |
4.497500E-03 |
| Stage1-vs-Stage2 |
6.057200E-01 |
| Stage1-vs-Stage3 |
9.233200E-04 |
| Stage1-vs-Stage4 |
8.742000E-03 |
| Stage2-vs-Stage3 |
6.781100E-03 |
| Stage2-vs-Stage4 |
5.829900E-02 |
| Stage3-vs-Stage4 |
5.544800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.19949614077564E-11 |
| Normal-vs-AfricanAmerican |
2.36699999999201E-05 |
| Normal-vs-Asian |
8.668300E-02 |
| Caucasian-vs-AfricanAmerican |
5.015000E-01 |
| Caucasian-vs-Asian |
3.213600E-01 |
| AfricanAmerican-vs-Asian |
1.323780E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.90285589904715E-12 |
| Normal-vs-Female |
2.18419999997721E-06 |
| Male-vs-Female |
2.246200E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.75590000000203E-05 |
| Normal-vs-Extreme_Weight |
3.5385999996862E-07 |
| Normal-vs-Obese |
4.29000000001789E-06 |
| Normal-vs-Extreme_Obese |
1.058470E-02 |
| Normal_Weight-vs-Extreme_Weight |
1.840360E-01 |
| Normal_Weight-vs-Obese |
4.452000E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.743800E-03 |
| Extreme_Weight-vs-Obese |
5.075700E-02 |
| Extreme_Weight-vs-Extreme_Obese |
8.416300E-03 |
| Obese-vs-Extreme_Obese |
5.241100E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.796500E-04 |
| Normal-vs-Age(41-60Yrs) |
2.27490026816213E-10 |
| Normal-vs-Age(61-80Yrs) |
1.81115999999815E-05 |
| Normal-vs-Age(81-100Yrs) |
8.856300E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.795700E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.315800E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.561400E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.126600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.371500E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.685000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.56990026218318E-10 |
| Normal-VS-Type2 PRCC |
3.1055000004887E-07 |
| Normal-VS-KIRP CIMP |
1.302470E-03 |
| Normal-VS-Unclassified PRCC |
2.759400E-04 |
| Type1 PRCC-VS-Type2 PRCC |
1.719770E-02 |
| Type1 PRCC-VS-KIRP CIMP |
2.961600E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
7.246300E-02 |
| Type2 PRCC-VS-KIRP CIMP |
6.763800E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
9.972200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
6.239500E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.84399999999729E-05 |
| Normal-vs-N1 |
2.99759999999871E-06 |
| Normal-vs-N2 |
8.215900E-02 |
| N0-vs-N1 |
2.640900E-04 |
| N0-vs-N2 |
1.919160E-01 |
| N1-vs-N2 |
2.689000E-01 |
|
|
